Dr. Angela Cacace is Arvinas’ chief scientific officer and previously served as senior vice president of neuroscience and platform biology. She has three decades of drug discovery experience in neuroscience and oncology.
Mr. Freedberg serves as General Counsel at Arvinas. He is responsible for providing legal guidance to senior management and the company’s board of directors, while also ensuring that a culture of compliance is maintained across the company.
Ms. Page is Senior Vice President, Global Head of Oncology Strategy and Program Leadership at Arvinas. She has over 25 years of global pharmaceutical industry experience from the research setting through global commercialization, with nearly 20 years of experience in oncology therapeutics.
The company’s executive committee, board of directors, and scientific advisory board comprise experts in the biotechnology and pharmaceutical industries.
